Adagio Medical Reports Positive vCLAS Results for VT
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
LOS ANGELES, April 2026 Adagio Medical announced positive pivotal clinical results for its vCLAS® Ventricular Ablation System, highlighting a...
December 22, 2025 | Abbott Park, Illinois — Abbott announced that the U.S. Food and Drug Administration (FDA) has...
